TypeO4life

Yes, agreed! Yes, agreed! Earlier someone said there was verbiage about any time over 72 hours being by day instead of time; I was really hoping the current Technical Manual said something similar.

Thanks for this information. I was hoping there was specific verbiage in either the AABB Technical Manual or the Circular of Information that talks about the expiration "time" for 5 day plasma. We are currently doing 120 hours, but I would like to change it to 2359 on the 5th day.

Does anyone have a recent reference for the expiration of more than 72 hours being number of days? I tried looking in the 19th Edition of the AABB Technical Manual and was not able to find this information.

Thank you for the response! I realize there are different densities, but I couldn't find information as to which was more dense, the transfused versus the patient's own cells? Which type of cells would remain at the top of the red cells when a tube is spun?

Has anyone had any issue with immunohematology automation (analyzers) picking up transfused red cells only for testing vs. transfused + autologous cells? My lab recently had two specimens, where it appears that the analyzer forward typed only transfused cells for recently transfused patients. This is via gel method. Tube method demonstrated a 4+ reaction when repeated. I repeated on a different lot of forward typing gel cards, and results were replicated. I read through previous threads about recommended specimen centrifuge times, and I'm starting to think my centrifuge may be to blame... please share your thoughts!

Our Erytra is going to be delivered in the next week! Would anyone be willing to share their validation plan? Also, any words of advice for the validation process? Was the TAS helpful for the validation and training?

it's been mentioned in passing in KB threads, but I wanted to ask anyway: Our hospital has been sending KB stain testing to a reference lab when trauma is the reason for testing. For reflex FMH screens, we perform the testing in-house. This was a practice long before I came on board, and I was told it was due to legal reasons. However, I could not find anything in the California state law and CFRs regarding this. Does anyone have any insight into legal regs around KB testing? If not, I'd like to either bring the testing in house, or send it all out.

Hi Maureen, Thank you for your response. Just to clarify, when EXM is done at Dispense and Assign, does the system automatically know that the patient is eligible for EXM? Or, are you just dispensing the unit? The way our system is set up, when dispensing, if the unit is not previously crossmatched, the system will think it is an emergency dispense and "not crossmatched." Please advise if possible.

Thank you Sophie1210 and butlermom for your responses! So it sounds like there are two options for E-XM in Cerner Millennium: 1) E-XM at time of test results from Result Entry. 2) E-XM at time of dispense via Dispense & Assign Products. What have you found are the biggest benefits to using electronic crossmatch? What are the biggest drawbacks? Have there been impacts on your bottom line for E-XM?

Is anyone out there currently using Cerner Millennium for electronic crossmatch? I would mostly like to know how and when the unit is assigned via electronic crossmatch. Does the computer automatically assign the unit, or is the unit to be electronically crossmatched scanned in to be assigned? Is the unit assigned in Result Entry for Blood Bank, or is it assigned when dispensing the unit? Any help to these questions would greatly appreciated?